1. Home
  2. HLLY vs GLUE Comparison

HLLY vs GLUE Comparison

Compare HLLY & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Holley Inc.

HLLY

Holley Inc.

HOLD

Current Price

$4.04

Market Cap

344.6M

ML Signal

HOLD

Logo Monte Rosa Therapeutics Inc.

GLUE

Monte Rosa Therapeutics Inc.

HOLD

Current Price

$17.90

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLLY
GLUE
Founded
1903
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.6M
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HLLY
GLUE
Price
$4.04
$17.90
Analyst Decision
Strong Buy
Buy
Analyst Count
7
2
Target Price
$4.43
$15.00
AVG Volume (30 Days)
1.0M
910.9K
Earning Date
11-07-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.25
Revenue
$598,132,000.00
$181,538,000.00
Revenue This Year
$1.75
$81.52
Revenue Next Year
$5.07
N/A
P/E Ratio
N/A
$70.71
Revenue Growth
N/A
1112.27
52 Week Low
$1.60
$3.50
52 Week High
$4.43
$18.15

Technical Indicators

Market Signals
Indicator
HLLY
GLUE
Relative Strength Index (RSI) 57.12 75.58
Support Level $3.58 $15.21
Resistance Level $3.90 $17.63
Average True Range (ATR) 0.18 0.98
MACD -0.01 0.11
Stochastic Oscillator 52.94 95.20

Price Performance

Historical Comparison
HLLY
GLUE

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: